Great Debates & Updates in GI Malignancies 2018
In-Person Event
Mar 23 - 24, 2018
New York, New York, USA
OVERVIEW
Great Debates & Updates in GI Malignancies is organized by Imedex and will be held during Mar 23 - 24, 2018 at New York Marriott Marquis, New York City, New York, United States of America.
The target audience for this medical event is oncologists and other healthcare professionals (physicians-in-training, oncology nurses, pharmacists, physician assistants, etc.) involved in the therapeutic management of patients with GI cancers.
Course Description:
To enhance clinical outcomes in patients with gastrointestinal malignancies, healthcare professionals require expert review and analysis of pertinent clinical data to effectively identify and integrate optimal therapeutic regimens into everyday clinical practice. To narrow the identified practice gaps and underlying educational needs, the following objectives will be addressed within the educational activities.
Conference Objectives are :
• Analyze the mechanism of action (MOA) and safety-efficacy profiles of currently approved and emerging oncological agents including immunotherapies for the management of GI malignancies
• Integrate clinical trial data and evidence-based therapies for improving clinical outcomes in patients with GI malignancies
• Evaluate the best practices and standards of care based on a multidisciplinary approach for the management of GI cancers
• Implement the rational use of immunotherapies in patients with GI malignancies on a case-by case basis
• Define patient populations most suitable for enrolling in GI clinical trials for progressive advanced stage GI malignancies
• Implement optimal management strategies for both metastatic and non-metastatic GI malignancies based on personalized factors such as comorbidities, cost, disease stage, and prior therapeutic regimens
Additional details will be posted as soon as they are available.
The target audience for this medical event is oncologists and other healthcare professionals (physicians-in-training, oncology nurses, pharmacists, physician assistants, etc.) involved in the therapeutic management of patients with GI cancers.
Course Description:
To enhance clinical outcomes in patients with gastrointestinal malignancies, healthcare professionals require expert review and analysis of pertinent clinical data to effectively identify and integrate optimal therapeutic regimens into everyday clinical practice. To narrow the identified practice gaps and underlying educational needs, the following objectives will be addressed within the educational activities.
Conference Objectives are :
• Analyze the mechanism of action (MOA) and safety-efficacy profiles of currently approved and emerging oncological agents including immunotherapies for the management of GI malignancies
• Integrate clinical trial data and evidence-based therapies for improving clinical outcomes in patients with GI malignancies
• Evaluate the best practices and standards of care based on a multidisciplinary approach for the management of GI cancers
• Implement the rational use of immunotherapies in patients with GI malignancies on a case-by case basis
• Define patient populations most suitable for enrolling in GI clinical trials for progressive advanced stage GI malignancies
• Implement optimal management strategies for both metastatic and non-metastatic GI malignancies based on personalized factors such as comorbidities, cost, disease stage, and prior therapeutic regimens
Additional details will be posted as soon as they are available.
KEY DATES
23 Mar, 2018
Event Start Date
24 Mar, 2018
Event End Date
SPECIALITIES
Gastrointestinal EndoscopySUGGESTED HOTELS
CONFERENCE VENUE
New York Marriott MarquisRELATED CONFERENCES & LIVE WEBINARS
Quick Links